Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest.
CDK4/6
EMP2
MBOAT1
MUFA
PUFA
ferroptosis
iron
lipid peroxidation
p53
palbociclib
Journal
Cell chemical biology
ISSN: 2451-9448
Titre abrégé: Cell Chem Biol
Pays: United States
ID NLM: 101676030
Informations de publication
Date de publication:
09 Nov 2023
09 Nov 2023
Historique:
received:
30
06
2023
revised:
19
08
2023
accepted:
13
10
2023
medline:
15
11
2023
pubmed:
15
11
2023
entrez:
14
11
2023
Statut:
aheadofprint
Résumé
Ferroptosis is a non-apoptotic form of cell death that can be triggered by inhibiting the system x
Identifiants
pubmed: 37963466
pii: S2451-9456(23)00372-0
doi: 10.1016/j.chembiol.2023.10.011
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM112948
Pays : United States
Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests J.A.O. is a member of the scientific advisory board for Vicinitas Therapeutics and an inventor on ferroptosis-related patent applications. S.J.D. is a co-founder of Prothegen Inc., a member of the scientific advisory board of Ferro Therapeutics and Hillstream Biopharma, and an inventor on patents related to ferroptosis.